Bioventus (BVS) Net Cash Flow (QoQ) (2020 - 2026)
Bioventus (BVS) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Bioventus | 571.68 Mn | 581.20 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -265.35% |
| Dec 31, 2025 | -7.33% |
| Sep 27, 2025 | -2.60% |
| Jun 28, 2025 | 151.57% |
| Mar 29, 2025 | -3,464.27% |
| Dec 31, 2024 | -94.62% |
| Sep 28, 2024 | 46.60% |
| Jun 29, 2024 | 164.37% |
| Mar 30, 2024 | -152.86% |
| Dec 31, 2023 | 45,165.96% |
| Sep 30, 2023 | 100.16% |
| Jul 1, 2023 | -211.97% |
| Apr 1, 2023 | 1,231.13% |
| Dec 31, 2022 | 57.88% |
| Oct 1, 2022 | 86.67% |
| Jul 2, 2022 | -151.28% |
| Apr 2, 2022 | 48.24% |
| Dec 31, 2021 | -358.65% |
| Oct 2, 2021 | -181.10% |
| Jul 3, 2021 | -80.01% |